Security key
68235C206
Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX)
CUSIP: 68235C206
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 32,330,312
- Total 13F shares
- 16,047,858
- Share change
- +7,679,219
- Total reported value
- $49,105,818
- Price per share
- $3.06
- Number of holders
- 29
- Value change
- +$23,516,169
- Number of buys
- 17
- Number of sells
- 9
Report period
Q1 2025
Institutions
29
Top holders
10
IMDX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C206
Recent filing periods:
Top shareholders of IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Patrick W. Smith |
3/4/5
13D/G
|
10%+ Owner |
10%
from 13D/G
|
3,258,485
|
$6,679,894 | — | 07 Feb 2025 | |
| AWM Investment Company, Inc. |
13D/G
13F
|
Company |
10%
|
2,857,069
|
$9,685,464 | +$5,257,076 | 31 Mar 2025 | |
| BIO-RAD LABORATORIES, INC. |
13D/G
|
— |
9.7%
|
2,764,078
|
$608,097 | $0 | 10 Feb 2025 | |
| BROADWOOD CAPITAL INC |
13F
|
Company |
19%
|
6,244,405
|
$14,861,684 | — | 31 Dec 2024 | |
| PURA VIDA INVESTMENTS, LLC |
3/4/5
13F
|
10%+ Owner · Company |
2%
from 13F
|
16,591,052
mixed-class rows
|
$3,044,309 | — | 14 Apr 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.75%
|
242,206
|
$576,450 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
137,069
|
$326,282 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
79,957
|
$190,298 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
61,708
|
$146,865 | — | 31 Dec 2024 | |
| Defender Capital, LLC. |
13F
|
Company |
0.17%
|
47,078
|
$112,046 | — | 31 Dec 2024 | |
| WEALTHEDGE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.16%
|
52,732
|
$125,502 | — | 31 Dec 2024 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.15%
|
49,377
|
$117,000 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
19,554
|
$46,539 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
17,333
|
$41,253 | — | 31 Dec 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.04%
|
13,215
|
$31,452 | — | 31 Dec 2024 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.03%
|
10,915
|
$25,978 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
4,313
|
$10,265 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,714
|
$6,460 | — | 31 Dec 2024 | |
| LEE DANNER & BASS INC |
13F
|
Company |
0%
|
1,388
|
$3,303 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
436
|
$1,038 | — | 31 Dec 2024 | |
| Wilmington Savings Fund Society, FSB |
13F
|
Company |
0%
|
250
|
$595 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
208
|
$495 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
195
|
$465 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
185
|
$440 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
182
|
$431 | — | 31 Dec 2024 | |
| Piscataqua Savings Bank |
13F
|
Company |
0%
|
25
|
$59 | — | 31 Dec 2024 | |
| Coppell Advisory Solutions LLC |
13F
|
Company |
0%
|
10
|
$24 | — | 31 Dec 2024 | |
| ALBION FINANCIAL GROUP /UT |
13F
|
Company |
0%
|
7
|
$17 | — | 31 Dec 2024 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2024 | |
| John Peter Gutfreund |
3/4/5
|
Former Director |
—
mixed-class rows
|
760,000
mixed-class rows
|
$153,654 | — | 30 Jun 2023 | |
| Ronald Asbury Andrews |
3/4/5
|
Former CEO, Director |
—
mixed-class rows
|
633,212
mixed-class rows
|
$125,332 | — | 01 Dec 2022 | |
| Alfred D. Kingsley |
3/4/5
|
Director |
—
mixed-class rows
|
597,878
mixed-class rows
|
$109,143 | — | 23 Jun 2023 | |
| Gisela Paulsen |
3/4/5
|
Former President and COO |
—
class O/S missing
|
366,500
|
$78,761 | — | 16 Dec 2022 | |
| Li Yu |
3/4/5
|
VP Cntrllr/Prncpl Acctng Offcr |
—
mixed-class rows
|
41,872
mixed-class rows
|
$76,536 | — | 18 May 2022 | |
| Ross Douglas T. |
3/4/5
|
Former CSO |
—
class O/S missing
|
234,114
|
$50,311 | — | 21 Dec 2022 | |
| Cavan M. Redmond |
3/4/5
|
Director |
—
class O/S missing
|
120,863
|
$25,973 | — | 24 Jun 2022 | |
| Mitchell S. Levine |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
174,580
mixed-class rows
|
$18,713 | — | 15 Mar 2022 | |
| Jennifer Levin Carter |
3/4/5
|
Director |
—
mixed-class rows
|
75,500
mixed-class rows
|
$6,554 | — | 15 Aug 2022 | |
| Melinda Griffith |
3/4/5
|
Director |
—
mixed-class rows
|
75,000
mixed-class rows
|
$6,447 | — | 15 Aug 2022 | |
| Anish M. John |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
121,381
|
— | — | 24 Feb 2023 | |
| Padmavathi Sundar |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
87,500
|
— | — | 15 Mar 2022 |
Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) as of Q1 2025
As of 31 Mar 2025,
Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,047,858 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, AWM Investment Company, Inc., PURA VIDA INVESTMENTS, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., WEALTHEDGE INVESTMENT ADVISORS, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
25
Q1 2025 holders
29
Holder diff
4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.